Clinical Trials Browser

OTHER × Multiple Sclerosis × 30 days × Clear all

NCT07526493 2026-04-13

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Multiple Sclerosis, Myasthenia Gravis, Myositis, Neuromyelitis Optica, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT05819008 2026-04-01

Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries

Recruiting

350 enrolled

CNS

Brain Injuries, Traumatic, Brain Neoplasms, Epilepsy, Multiple Sclerosis, Parkinson Disease, Stroke